Country: USA

Pfizer announced Tuesday that its maternal RSV vaccine, given during pregnancy, protected infants from developing severe symptoms during…

Working through the spring of 2021, the CSIS-LSHTM High-Level Panel on Vaccine Confidence and Misinformation analysed the diverse forms of vaccine hesitancy in the United States and their links to international phenomena.

Between October 31, 2020 and December 15, 2020, 26,759 individuals were surveyed across 32 countries via nationally representative survey designs.

This briefing provides a summary of the report…

This report argues that vaccine confidence is essential to ensuring national security, and recommends bolstering confidence-building efforts in five critical areas.

In this study, we aimed to build upon recent advances in Transformer-based…

To inform successful vaccination campaigns, we conducted a randomized controlled trial in the UK and…

Falling U.S. confidence in a COVID-19 vaccine threatens efforts to escape the worst effects of the pandemic.

Combating misinformation about COVID-19 and strengthening the U.S.

This is the first systematic review and meta-analysis to examine the strength of the relationships between…

CSIS and the London School of Hygiene and Tropical Medicine’s Vaccine Confidence Project™ have launched a…

Maternal vaccination offers the potential to tackle the sustainable development goal 3 (SDG3) to reduce neonatal and maternal vaccination globally.